These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18494516)

  • 1. Evaluation of ketone-oxime method for developing therapeutic on-demand cleavable immunoconjugates.
    Kumaresan PR; Luo J; Song A; Marik J; Lam KS
    Bioconjug Chem; 2008 Jun; 19(6):1313-8. PubMed ID: 18494516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On-demand cleavable linkers for radioimmunotherapy.
    Kumaresan PR; Luo J; Lam KS
    Methods Mol Biol; 2009; 539():191-211. PubMed ID: 19377973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Reagent development.
    Karacay H; Sharkey RM; Govindan SV; McBride WJ; Goldenberg DM; Hansen HJ; Griffiths GL
    Bioconjug Chem; 1997; 8(4):585-94. PubMed ID: 9258459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regioselective labeling of antibodies through N-terminal transamination.
    Scheck RA; Francis MB
    ACS Chem Biol; 2007 Apr; 2(4):247-51. PubMed ID: 17455901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo drug-linker stability of an anti-CD30 dipeptide-linked auristatin immunoconjugate.
    Sanderson RJ; Hering MA; James SF; Sun MM; Doronina SO; Siadak AW; Senter PD; Wahl AF
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):843-52. PubMed ID: 15701875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-specifically traced drug release and biodistribution of a paclitaxel-antibody conjugate toward improvement of the linker structure.
    Safavy A; Georg GI; Vander Velde D; Raisch KP; Safavy K; Carpenter M; Wang W; Bonner JA; Khazaeli MB; Buchsbaum DJ
    Bioconjug Chem; 2004; 15(6):1264-74. PubMed ID: 15546192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor delivery and in vivo processing of disulfide-linked and thioether-linked antibody-maytansinoid conjugates.
    Erickson HK; Widdison WC; Mayo MF; Whiteman K; Audette C; Wilhelm SD; Singh R
    Bioconjug Chem; 2010 Jan; 21(1):84-92. PubMed ID: 19891424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody conjugates of doxorubicin prepared with branched linkers: A novel method for increasing the potency of doxorubicin immunoconjugates.
    King HD; Yurgaitis D; Willner D; Firestone RA; Yang MB; Lasch SJ; Hellström KE; Trail PA
    Bioconjug Chem; 1999; 10(2):279-88. PubMed ID: 10077478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and in vitro evaluation of dipeptide-based antibody minor groove binder conjugates.
    Jeffrey SC; Torgov MY; Andreyka JB; Boddington L; Cerveny CG; Denny WA; Gordon KA; Gustin D; Haugen J; Kline T; Nguyen MT; Senter PD
    J Med Chem; 2005 Mar; 48(5):1344-58. PubMed ID: 15743178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of TNKase-specific cleavable peptide-linked radioimmunoconjugates for radioimmunotherapy.
    Natarajan A; Kumaresan PR; Denardo SJ; Denardo GL; Mirick G; Lam KS
    Bioorg Med Chem Lett; 2008 Sep; 18(17):4802-5. PubMed ID: 18701282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted drug delivery using immunoconjugates: principles and applications.
    Pasquetto MV; Vecchia L; Covini D; Digilio R; Scotti C
    J Immunother; 2011; 34(9):611-28. PubMed ID: 21989410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of linker stability to the activities of anticancer immunoconjugates.
    Alley SC; Benjamin DR; Jeffrey SC; Okeley NM; Meyer DL; Sanderson RJ; Senter PD
    Bioconjug Chem; 2008 Mar; 19(3):759-65. PubMed ID: 18314937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Studies in a human colon cancer xenograft model.
    Sharkey RM; Karacay H; Griffiths GL; Behr TM; Blumenthal RD; Mattes MJ; Hansen HJ; Goldenberg DM
    Bioconjug Chem; 1997; 8(4):595-604. PubMed ID: 9258460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel immunoconjugates comprised of streptonigrin and 17-amino-geldanamycin attached via a dipeptide-p-aminobenzyl-amine linker system.
    Burke PJ; Toki BE; Meyer DW; Miyamoto JB; Kissler KM; Anderson M; Senter PD; Jeffrey SC
    Bioorg Med Chem Lett; 2009 May; 19(10):2650-3. PubMed ID: 19386499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of immunoconjugates using antibody oligosaccharide moieties.
    Vogel CW
    Methods Mol Biol; 2004; 283():87-108. PubMed ID: 15197304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of different hapten-carrier conjugation ratios and molecular orientations on antibody affinity against a peptide antigen.
    Pedersen MK; Sorensen NS; Heegaard PM; Beyer NH; Bruun L
    J Immunol Methods; 2006 Apr; 311(1-2):198-206. PubMed ID: 16574142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and comparison of antibody recognition of conjugates containing herpes simplex virus type 1 glycoprotein D epitope VII.
    Mezö G; de Oliveira E; Krikorian D; Feijlbrief M; Jakab A; Tsikaris V; Sakarellos C; Welling-Wester S; Andreu D; Hudecz F
    Bioconjug Chem; 2003; 14(6):1260-9. PubMed ID: 14624643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conjugation of anticancer drugs through endogenous monoclonal antibody cysteine residues.
    Lyon RP; Meyer DL; Setter JR; Senter PD
    Methods Enzymol; 2012; 502():123-38. PubMed ID: 22208984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphipathic peptide-based fusion peptides and immunoconjugates for the targeted ablation of prostate cancer cells.
    Rege K; Patel SJ; Megeed Z; Yarmush ML
    Cancer Res; 2007 Jul; 67(13):6368-75. PubMed ID: 17616696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and preclinical assessment of folate-conjugated, radiolabelled antibodies.
    Henriksen G; Bruland OS; Larsen RH
    Anticancer Res; 2005; 25(1A):9-15. PubMed ID: 15816513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.